Ocular drift, a very subtle and seemingly random type of eye movement, can be influenced by prior knowledge of the expected visual target, suggesting a surprising level of cognitive control over the eyes, according to a study led by Weill Cornell Medicine neuroscientists.
Hospitals have begun using “decision support tools” powered by artificial intelligence that can diagnose disease, suggest treatment or predict a surgery’s outcome.
White blood cells called neutrophils have an unappreciated role in eradicating solid tumors, according to a surprise discovery from a team led by Weill Cornell Medicine scientists.
Cornell’s Office of General Counsel, to engage proactively with groups across campuses, is planning a series of four workshops designed to educate Cornell community members on common legal challenges in higher education.
A specific toxin-producing gut bacteria may be responsible for both triggering the onset of multiple sclerosis (MS) and ongoing disease activity, according to a new study led by a team of researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Ekta Khurana, associate professor of physiology and biophysics at Weill Cornell Medicine, has received a three-year, $1.2 million grant from the United States Department of Defense to investigate how prostate cancer cells evolve to become resistant to hormone-blocking therapy.
Multiple types of beta cells produce insulin in the pancreas, helping to balance blood sugar levels. Losing a particularly productive type of beta cell may contribute to the development of diabetes, according to a new study by Weill Cornell Medicine investigators.
Obesity may spur DNA damage in the breast tissue of women who carry BRCA1 or BRCA2 mutations, possibly contributing to breast cancer development in this already high-risk group, according to new multi-institutional translational research led by Weill Cornell Medicine scientists.
